1. Home
  2. ALMS vs DXYZ Comparison

ALMS vs DXYZ Comparison

Compare ALMS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • DXYZ
  • Stock Information
  • Founded
  • ALMS 2021
  • DXYZ N/A
  • Country
  • ALMS United States
  • DXYZ
  • Employees
  • ALMS N/A
  • DXYZ N/A
  • Industry
  • ALMS
  • DXYZ
  • Sector
  • ALMS
  • DXYZ
  • Exchange
  • ALMS NYSE
  • DXYZ Nasdaq
  • Market Cap
  • ALMS 402.6M
  • DXYZ 334.3M
  • IPO Year
  • ALMS 2024
  • DXYZ 2024
  • Fundamental
  • Price
  • ALMS $4.10
  • DXYZ $30.37
  • Analyst Decision
  • ALMS Strong Buy
  • DXYZ
  • Analyst Count
  • ALMS 6
  • DXYZ 0
  • Target Price
  • ALMS $19.80
  • DXYZ N/A
  • AVG Volume (30 Days)
  • ALMS 692.8K
  • DXYZ N/A
  • Earning Date
  • ALMS 08-12-2025
  • DXYZ N/A
  • Dividend Yield
  • ALMS N/A
  • DXYZ N/A
  • EPS Growth
  • ALMS N/A
  • DXYZ N/A
  • EPS
  • ALMS N/A
  • DXYZ N/A
  • Revenue
  • ALMS $17,389,000.00
  • DXYZ N/A
  • Revenue This Year
  • ALMS N/A
  • DXYZ N/A
  • Revenue Next Year
  • ALMS N/A
  • DXYZ N/A
  • P/E Ratio
  • ALMS N/A
  • DXYZ N/A
  • Revenue Growth
  • ALMS N/A
  • DXYZ N/A
  • 52 Week Low
  • ALMS $2.76
  • DXYZ N/A
  • 52 Week High
  • ALMS $13.20
  • DXYZ N/A
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • DXYZ N/A
  • Support Level
  • ALMS N/A
  • DXYZ N/A
  • Resistance Level
  • ALMS N/A
  • DXYZ N/A
  • Average True Range (ATR)
  • ALMS 0.00
  • DXYZ 0.00
  • MACD
  • ALMS 0.00
  • DXYZ 0.00
  • Stochastic Oscillator
  • ALMS 0.00
  • DXYZ 0.00

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: